Alignment Healthcare CEO plans 405K share sale

CEO John Kao has filed a Rule 144 notice to sell shares of ALHC common stock in sale-to-cover transactions tied to vested equity awards.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) disclosed a planned sale of up to 405,000 shares of common stock under Rule 144 for the account of Chief Executive Officer and Director John Kao. The shares relate to equity awards, including 819,513 shares acquired through vesting of restricted stock units on September 12, 2022 under the company’s 2021 Equity Incentive Plan.

The notice states that the transaction is a sale-to-cover for tax withholding and does not represent a discretionary trade by John Kao; the actual number of shares sold will depend on applicable tax withholding rates and the stock price at the time of sale. In the prior three months, entities under a 10b5-1 Sales Plan associated with Kao reported three sales of 298,000 shares each.

Key Figures

Shares to be sold under Rule 144: 405,000 shares Aggregate market value of planned sale: $5,289,300 Shares outstanding: 207,435,149 shares +4 more

7 metrics

Shares to be sold under Rule 144 405,000 shares Planned sale of Alignment Healthcare common stock for John Kao

Aggregate market value of planned sale $5,289,300 Estimated value of 405,000 shares of common stock

Shares outstanding 207,435,149 shares Alignment Healthcare common stock outstanding as of September 10, 2026

RSU shares acquired 819,513 shares Shares acquired via RSU vesting on September 12, 2022 under 2021 Equity Incentive Plan

Recent 10b5-1 sale on June 10, 2026 298,000 shares for $6,066,620.78 JEK TRUST U/A DTD 02/08/2021 10b5-1 Sales Plan

Recent 10b5-1 sale on July 10, 2026 298,000 shares for $5,919,361.02 JEK TRUST U/A DTD 02/08/2021 10b5-1 Sales Plan

Recent 10b5-1 sale on August 10, 2026 298,000 shares for $4,136,776.40 JEK TRUST U/A DTD 02/08/2021 10b5-1 Sales Plan

Key Terms

Rule 144, 10b5-1 Sales Plan, restricted stock units, sale-to-cover transaction, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021"

A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.

restricted stock units financial

"The Common Stock was acquired through the vesting of restricted stock units granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sale-to-cover transaction financial

"Shares sold pursuant to a sale-to-cover transaction and does not represent"

Equity Incentive Plan financial

"granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

What does the Form 144 filing mean for Alignment Healthcare (ALHC)?

The Form 144 notice reports that John Kao, CEO and Director of ALHC, may sell up to 405,000 shares of common stock under Rule 144. The filing outlines the potential sale, its basis in equity awards, and recent related sales under a 10b5-1 plan.

How many Alignment Healthcare (ALHC) shares are covered by this Form 144?

The notice covers a proposed sale of up to 405,000 shares of ALHC common stock. It also notes that 819,513 shares were previously acquired through vesting of restricted stock units on September 12, 2022 under the 2021 Equity Incentive Plan.

What type of transaction is CEO John Kao planning for ALHC shares?

The filing states the shares will be sold in a sale-to-cover transaction for tax withholding, and that it does not represent a discretionary trade by John Kao. The actual number of shares sold will depend on tax withholding rates and the stock price at the time of sale.

What recent ALHC stock sales are disclosed for John Kao’s 10b5-1 plan?

Over the past three months, a 10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 reported three ALHC common stock sales of 298,000 shares each on June 10, July 10, and August 10, 2026, with proceeds of $6,066,620.78, $5,919,361.02, and $4,136,776.40, respectively.

How many Alignment Healthcare (ALHC) shares are outstanding in this filing?

The filing reports 207,435,149 shares of ALHC common stock outstanding as of September 10, 2026. This figure serves as a context baseline for the potential 405,000-share sale reported in the Form 144 notice.

How were the ALHC shares to be sold by John Kao originally acquired?

The Form 144 explains that the common stock was acquired through the vesting of restricted stock units granted on September 12, 2022 under Alignment Healthcare’s 2021 Equity Incentive Plan, linking the planned sale to previously granted equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 05:58 PM Accepted by SEC EDGAR 09/09/2026 - 05:57 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222028
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	844-310-2247
Name of Person for Whose Account the Securities are To Be Sold	John Kao
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Executive Officer / Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	405000	5289300	207435149	09/10/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/12/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			819513	09/12/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	08/10/2026	298000	4136776.4
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	07/10/2026	298000	5919361.02
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/10/2026	298000	6066620.78

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Kao
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)